These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 28592766)

  • 21. Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease.
    Zhang F; Zuo T; Yeoh YK; Cheng FWT; Liu Q; Tang W; Cheung KCY; Yang K; Cheung CP; Mo CC; Hui M; Chan FKL; Li CK; Chan PKS; Ng SC
    Nat Commun; 2021 Jan; 12(1):65. PubMed ID: 33397897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal Microbiota Transplantation in Experimental Ulcerative Colitis Reveals Associated Gut Microbial and Host Metabolic Reprogramming.
    Yan ZX; Gao XJ; Li T; Wei B; Wang PP; Yang Y; Yan R
    Appl Environ Microbiol; 2018 Jul; 84(14):. PubMed ID: 29728388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation.
    Elangovan A; Allegretti JR; Fischer M
    Expert Opin Biol Ther; 2019 Dec; 19(12):1343-1355. PubMed ID: 31570017
    [No Abstract]   [Full Text] [Related]  

  • 24. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
    Kumari R; Palaniyandi S; Hildebrandt GC
    Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial.
    Zhao Y; Li X; Zhou Y; Gao J; Jiao Y; Zhu B; Wu D; Qi X
    Front Immunol; 2021; 12():678476. PubMed ID: 34220825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection.
    Ouyang J; Isnard S; Lin J; Fombuena B; Peng X; Nair Parvathy S; Chen Y; Silverman MS; Routy JP
    Front Med (Lausanne); 2020; 7():421. PubMed ID: 32850913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential of Fecal Microbiota Transplantation to Prevent Acute GVHD: Analysis from a Phase II Trial.
    Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C
    Clin Cancer Res; 2023 Dec; 29(23):4920-4929. PubMed ID: 37787998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis.
    Wei Y; Yang J; Wang J; Yang Y; Huang J; Gong H; Cui H; Chen D
    Crit Care; 2016 Oct; 20(1):332. PubMed ID: 27751177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract.
    DeFilipp Z; Damania AV; Kim HT; Chang CC; El-Jawahri A; McAfee SL; Bottoms AS; Toncheva V; Smith MM; Dolaher M; Perry L; White M; Diana B; Connolly S; Dey BR; Frigault MJ; Newcomb RA; O'Donnell PV; Spitzer TR; Mansour MK; Weber D; Ajami NJ; Hohmann E; Jenq RR; Chen YB
    Blood Adv; 2024 May; 8(9):2074-2084. PubMed ID: 38471063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study.
    Youngster I; Eshel A; Geva M; Danylesko I; Henig I; Zuckerman T; Fried S; Yerushalmi R; Shem-Tov N; Fein JA; Bomze D; Shimoni A; Koren O; Shouval R; Nagler A
    Bone Marrow Transplant; 2024 Mar; 59(3):409-416. PubMed ID: 38212672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.
    DeFilipp Z; Peled JU; Li S; Mahabamunuge J; Dagher Z; Slingerland AE; Del Rio C; Valles B; Kempner ME; Smith M; Brown J; Dey BR; El-Jawahri A; McAfee SL; Spitzer TR; Ballen KK; Sung AD; Dalton TE; Messina JA; Dettmer K; Liebisch G; Oefner P; Taur Y; Pamer EG; Holler E; Mansour MK; van den Brink MRM; Hohmann E; Jenq RR; Chen YB
    Blood Adv; 2018 Apr; 2(7):745-753. PubMed ID: 29592876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals.
    Vujkovic-Cvijin I; Rutishauser RL; Pao M; Hunt PW; Lynch SV; McCune JM; Somsouk M
    Gut Microbes; 2017 Sep; 8(5):440-450. PubMed ID: 28541799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal Microbiota Transplantation for Treatment of Acute Graft-
    Shouval R; Geva M; Nagler A; Youngster I
    Clin Hematol Int; 2019 Mar; 1(1):28-35. PubMed ID: 34595408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
    Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
    J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor Considerations in Fecal Microbiota Transplantation.
    Barnes D; Park KT
    Curr Gastroenterol Rep; 2017 Mar; 19(3):10. PubMed ID: 28289858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal Microbiota Transplantation for the Critically Ill Patient.
    Limketkai BN; Hendler S; Ting PS; Parian AM
    Nutr Clin Pract; 2019 Feb; 34(1):73-79. PubMed ID: 30561131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The gut microbiota and graft-versus-host disease.
    Fredricks DN
    J Clin Invest; 2019 May; 129(5):1808-1817. PubMed ID: 31042160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation.
    Doki N; Suyama M; Sasajima S; Ota J; Igarashi A; Mimura I; Morita H; Fujioka Y; Sugiyama D; Nishikawa H; Shimazu Y; Suda W; Takeshita K; Atarashi K; Hattori M; Sato E; Watakabe-Inamoto K; Yoshioka K; Najima Y; Kobayashi T; Kakihana K; Takahashi N; Sakamaki H; Honda K; Ohashi K
    Ann Hematol; 2017 Sep; 96(9):1517-1523. PubMed ID: 28733895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases.
    Cammarota G; Pecere S; Ianiro G; Masucci L; Currò D
    Dig Dis; 2016; 34(3):279-85. PubMed ID: 27027524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases.
    Konturek PC; Haziri D; Brzozowski T; Hess T; Heyman S; Kwiecien S; Konturek SJ; Koziel J
    J Physiol Pharmacol; 2015 Aug; 66(4):483-91. PubMed ID: 26348073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.